Roger H. Brookes

5.2k total citations · 1 hit paper
72 papers, 4.3k citations indexed

About

Roger H. Brookes is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Roger H. Brookes has authored 72 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 33 papers in Epidemiology and 33 papers in Immunology. Recurrent topics in Roger H. Brookes's work include Tuberculosis Research and Epidemiology (32 papers), Mycobacterium research and diagnosis (17 papers) and Immunotherapy and Immune Responses (14 papers). Roger H. Brookes is often cited by papers focused on Tuberculosis Research and Epidemiology (32 papers), Mycobacterium research and diagnosis (17 papers) and Immunotherapy and Immune Responses (14 papers). Roger H. Brookes collaborates with scholars based in United Kingdom, Gambia and Canada. Roger H. Brookes's co-authors include Adrian V. S. Hill, Ajit Lalvani, Helen McShane, Philip C. Hill, Warwick J. Britton, Sophie Hambleton, Andrew J. McMichael, Richard A. Adegbola, Annette Fox and Simon Donkor and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Roger H. Brookes

69 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Effector Function in CD8+ Memory T Cells

1997 573 citations Ajit Lalvani, Roger H. Brookes et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Roger H. Brookes

Since Specialization

Citations

This map shows the geographic impact of Roger H. Brookes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger H. Brookes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger H. Brookes more than expected).

Fields of papers citing papers by Roger H. Brookes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger H. Brookes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger H. Brookes. The network helps show where Roger H. Brookes may publish in the future.

Co-authorship network of co-authors of Roger H. Brookes

This figure shows the co-authorship network connecting the top 25 collaborators of Roger H. Brookes. A scholar is included among the top collaborators of Roger H. Brookes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger H. Brookes. Roger H. Brookes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Self‐Care Interventions for Children and Young People With Neurodisabilities: A Mixed Methods Study of Current Therapy Practice in the United Kingdom 2025 ·Child Care Health and Development ·(unknown), Tim Rapley, Niina Kolehmainen, Lindsay Pennington, Elaine McColl, (unknown), Roger H. Brookes, (unknown)	0
2	A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge 2016 ·Human Vaccines & Immunotherapeutics ·Martina M. Ochs, (unknown), Anthony Sheung, (unknown), Lucian Visan, Nicolas Rouleau, (unknown), (unknown), Mei San Tang, Karine Mari, Robert Hopfer, Scott Gallichan, Roger H. Brookes	11
3	Screening Vaccine Formulations in Fresh Human Whole Blood 2016 ·Methods in molecular biology ·Jalil Hakimi, (unknown), (unknown), Salvador F. Ausar, (unknown), Roger H. Brookes	6
4	Mucosal Receptors and T- and B-Cell Immunity1 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·Thomas Lehner, Lesley A. Bergmeier, Louisa Tao, Roger H. Brookes, L Hussain, Linda S. Klavinskis, Elaine Mitchell	0
5	Passive protection of mice againstStreptococcus pneumoniaechallenge by naturally occurring and vaccine-induced human anti-PhtD antibodies 2015 ·Human Vaccines & Immunotherapeutics ·Roger H. Brookes, (unknown), (unknown), Robert Hopfer, Sanjay Gurunathan, Scott Gallichan, Mei San Tang, Martina M. Ochs	14
6	Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection 2012 ·American Journal of Respiratory and Critical Care Medicine ·Ifedayo Adetifa, Martin O. C. Ota, David Jeffries, Moses D. Lugos, Abdulrahman S. Hammond, Nicholas J. Battersby, Patrick K. Owiafe, (unknown), Martín Antonio, (unknown), Roger H. Brookes, Peter Aka, Robert Walton, Richard A. Adegbola, Philip C. Hill	44
7	Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children 2012 ·European Journal of Clinical Microbiology & Infectious Diseases ·Ann Hagerman, Klara M. Posfay‐Barbe, Stéphane Grillet, Martina M. Ochs, Roger H. Brookes, David Greenberg, Noga Givon‐Lavi, Ron Dagan, Claire‐Anne Siegrist	6
8	Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa 2008 ·PLoS ONE ·Roger H. Brookes, Philip C. Hill, Patrick K. Owiafe, (unknown), David Jeffries, Simon Donkor, Helen A. Fletcher, Abdulrahman S. Hammond, Christian Lienhardt, Richard A. Adegbola, Helen McShane, Adrian V. S. Hill	40
9	Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts 2008 ·PLoS ONE ·Philip C. Hill, Dolly Jackson-Sillah, Annette Fox, Roger H. Brookes, Bouke C. de Jong, Moses D. Lugos, Ifedayo Adetifa, Simon Donkor, (unknown), Stephen R. C. Howie, Tumani Corrah, Keith P. W. J. McAdam, Richard A. Adegbola	101
10	Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor 2008 ·International Immunology ·Verena Voelter, Nathalie Rufer, Stéphanie Reynard, Gilbert Greub, Roger H. Brookes, Philippe Guillaume, F. Grosjean, (unknown), (unknown), Sarah Rowland‐Jones, Clemencia Pinilla, Serge Leyvraz, Pedro Romero, Victor Appay	13
11	Using ELISPOT to Expose False Positive Skin Test Conversion in Tuberculosis Contacts 2007 ·PLoS ONE ·Philip C. Hill, David Jeffries, Roger H. Brookes, Annette Fox, Dolly Jackson-Sillah, Moses D. Lugos, Simon Donkor, Bouke C. de Jong, Tumani Corrah, Richard A. Adegbola, Keith P. W. J. McAdam	31
12	Surprisingly High Specificity of the PPD Skin Test for M. tuberculosis Infection from Recent Exposure in The Gambia 2006 ·PLoS ONE ·Philip C. Hill, Roger H. Brookes, Annette Fox, Dolly Jackson-Sillah, Moses D. Lugos, David Jeffries, Simon Donkor, Richard A. Adegbola, Keith P. W. J. McAdam	18
13	Mycobacterium africanumElicits an Attenuated T Cell Response to Early Secreted Antigenic Target, 6 kDa, in Patients with Tuberculosis and Their Household Contacts 2006 ·The Journal of Infectious Diseases ·Bouke C. de Jong, Philip C. Hill, Roger H. Brookes, Sébastien Gagneux, David Jeffries, Jacob Otu, Simon Donkor, Annette Fox, Keith P. W. J. McAdam, Peter M. Small, Richard A. Adegbola	68
14	Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guerin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara 2003 ·The Journal of Immunology ·Nilu Goonetilleke, Helen McShane, Carolyn M. Hannan, Richard Anderson, Roger H. Brookes, Adrian V. S. Hill	313
15	CD8⁺ T cell‐mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages 2003 ·European Journal of Immunology ·Roger H. Brookes, Ansar A. Pathan, Helen McShane, Meike Hensmann, David A. Price, Adrian V. S. Hill	38
16	Rapid Effector Function in CD8+ Memory T Cells breakdown → 1997 ·The Journal of Experimental Medicine ·Ajit Lalvani, Roger H. Brookes, Sophie Hambleton, Warwick J. Britton, Adrian V. S. Hill, Andrew J. McMichael	573
17	Genital-Associated Lymphoid Tissue in Female Non-Human Primates 1995 ·Advances in experimental medicine and biology ·Thomas Lehner, C Panagiotidi, Lesley A. Bergmeier, Louisa Tao, Roger H. Brookes, Andy J.H. Gearing, Sally E. Adams	9
18	Isolation of a human T cell line specific for a streptococcal cell surface antigen 1991 ·FEMS Microbiology Letters ·Roger H. Brookes, Lee S. Rayfield, Lesley A. Bergmeier, P Shepherd	0
19	Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma 1987 ·Cancer Immunology Immunotherapy ·Roger H. Brookes, (unknown), (unknown)	8
20	Urinary thiamine excretion after oral physiological doses of the vitamin. 1984 ·PubMed ·(unknown), Roger H. Brookes, James McCulloch, (unknown), J. Metz	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact